QuantLogix

ABBV vs BMY — live signal comparison

Head-to-head on QuantLogix's 5-factor quant engine, recomputed throughout the trading day. An engine-read comparison — not a recommendation.

ABBV
ABBVIE INC.
59/100
BUY
$227.73 · +1.19% · $397.1B
50% of similar setups up in 5d
Full scorecard →
VS
engine lead
BMY
Bristol-Myers Squibb Co.
63/100
BUY
$57.13 · +0.52% · $116.2B
46% of similar setups up in 5d
Full scorecard →
Factor by factor — ABBV (left) vs BMY (right)
61
Technical
67
63
Momentum
50
54
Fundamental
63
60
Options
77

QuantLogix's 5-factor engine currently reads ABBVIE INC. (ABBV) at 59/100 (buy) and Bristol-Myers Squibb Co. (BMY) at 63/100 (buy). BMY carries the stronger composite read by 4 points, led by options at 77/100. ABBV's strongest leg is momentum at 63/100. In pattern backtesting, 50% of 50 ABBV setups and 46% of 50 BMY setups rose within five trading days. Signals recompute throughout the trading day — the balance can shift with the tape.

Track BMY with free signal alerts Browse all scorecards
🤖 Want the deeper take? Pro runs a 10-agent AI debate on either name — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Educational market analysis, not investment advice. QuantLogix does not provide personalized recommendations. ABBV scorecard · BMY scorecard · ABBV earnings · BMY earnings · Today's movers · Verified track record